Have a feature idea you'd love to see implemented?
Let us know!
NVRO Nevro Corp
Price (delayed)
$3.79
Market cap
$142.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.88
Enterprise value
$316.02M
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain.
Highlights
The EPS has increased by 34% year-on-year and by 11% since the previous quarter
The net income has grown by 32% YoY and by 11% from the previous quarter
NVRO's quick ratio is down by 25% year-on-year but it is up by 7% since the previous quarter
The debt is up by 27% year-on-year
The equity has contracted by 4.2% YoY
Key stats
What are the main financial stats of NVRO
Market
Valuations
Earnings
Shares outstanding
37.47M
Market cap
$142.02M
Enterprise value
$316.02M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.52
Price to sales (P/S)
0.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.75
Revenue
$419.15M
Gross profit
$285.09M
Net income
-$69.31M
EBIT
-$51.54M
EBITDA
-$37.46M
Free cash flow
-$56.61M
Per share
Balance sheet
Liquidity
EPS
-$1.88
EPS diluted
-$1.88
Free cash flow per share
-$1.52
Book value per share
$7.34
Revenue per share
$11.23
TBVPS
$14.26
Total assets
$595.65M
Total liabilities
$322.01M
Debt
$246.59M
Equity
$273.64M
Working capital
$383.83M
Debt to equity
0.9
Current ratio
5.02
Quick ratio
3.65
Net debt/EBITDA
-4.65
Margins
Efficiency
Dividend
EBITDA margin
-8.9%
Gross margin
68%
Net margin
-16.5%
Operating margin
-19.9%
Return on assets
-11.4%
Return on equity
-24.8%
Return on invested capital
-8.6%
Return on capital employed
-10.3%
Return on sales
-12.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NVRO stock price
How has the Nevro stock price performed over time
Intraday
5.57%
1 week
-6.88%
1 month
-10.4%
1 year
-82%
YTD
-82.39%
QTD
-32.2%
Financial performance
How have Nevro's revenue and profit performed over time
Revenue
$419.15M
Gross profit
$285.09M
Operating income
-$83.48M
Net income
-$69.31M
Gross margin
68%
Net margin
-16.5%
The net income has grown by 32% YoY and by 11% from the previous quarter
The net margin is up by 32% year-on-year and by 9% since the previous quarter
NVRO's operating income is up by 22% YoY and by 11% QoQ
The operating margin has grown by 21% YoY and by 10% from the previous quarter
Growth
What is Nevro's growth rate over time
Valuation
What is Nevro stock price valuation
P/E
N/A
P/B
0.52
P/S
0.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.75
The EPS has increased by 34% year-on-year and by 11% since the previous quarter
NVRO's P/B is 94% below its 5-year quarterly average of 8.2 and 68% below its last 4 quarters average of 1.6
The equity has contracted by 4.2% YoY
The P/S is 95% lower than the 5-year quarterly average of 6.6 and 69% lower than the last 4 quarters average of 1.1
Efficiency
How efficient is Nevro business performance
The return on sales has increased by 45% year-on-year and by 20% since the previous quarter
The company's return on invested capital rose by 44% YoY and by 21% QoQ
The ROA has grown by 36% YoY and by 12% from the previous quarter
NVRO's return on equity is up by 27% year-on-year and by 9% since the previous quarter
Dividends
What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NVRO.
Financial health
How did Nevro financials performed over time
NVRO's total assets is 85% greater than its total liabilities
NVRO's quick ratio is down by 25% year-on-year but it is up by 7% since the previous quarter
Nevro's current ratio has decreased by 23% YoY but it has increased by 5% QoQ
The debt is 10% smaller than the equity
The debt to equity has increased by 32% YoY and by 2.3% QoQ
The debt is up by 27% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.